Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA)

NCT04361500 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT04361500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04361500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA)
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2020
Completion date
October 1, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19